<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Since the recognition of <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e>, which confers a high risk of colorectal, uterine, and other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, approaches to its diagnosis have included a family history of associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> and web-based algorithms </plain></SENT>
<SENT sid="1" pm="."><plain>Identification of causative genes now allows a precise diagnosis, thus focusing present efforts on who should have genetic testing </plain></SENT>
<SENT sid="2" pm="."><plain>Testing for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue changes can determine who should have germline genetic testing </plain></SENT>
<SENT sid="3" pm="."><plain>Indeed, such <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> testing is now generally recommended for <z:hpo ids='HP_0000001'>all</z:hpo> newly diagnosed <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cases </plain></SENT>
<SENT sid="4" pm="."><plain>As reported in this issue of the journal by Yurgelun and colleagues (beginning on page 574), large colorectal <z:mpath ids='MPATH_490'>adenomatous polyps</z:mpath> (â‰¥10 mm) from patients with <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> exhibit findings similar to those in <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissues </plain></SENT>
<SENT sid="5" pm="."><plain>This finding indicates that testing larger <z:mpath ids='MPATH_270'>adenomas</z:mpath> in persons at a significant risk for <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> can now determine the need for germline genetic testing </plain></SENT>
<SENT sid="6" pm="."><plain>Although further study is needed for general application, the present study justifies large <z:mpath ids='MPATH_491'>polyp</z:mpath> testing in high-risk families when <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue is unavailable, albeit negative <z:mpath ids='MPATH_491'>polyp</z:mpath> tissue would not rule out <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e>, as would negative <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue </plain></SENT>
</text></document>